Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
2 Journal of Chromatography A (PubMed)Doping-control analysis of TB-500 as a synthetic thymosin beta-4 fragment in biological samples
Every published human study of BPC-157
Because of its ability to assist in the regulation of oxidative stress, production of cytokines, and overall immune response, the use of GSH and precursors like NAC have become increasingly popular as potential medicinal agents for autoimmune and neurodegenerative diseases such as AD, PD, and MS that involve inflammation and unregulated immune response (Tieu et al., 2023
BPC-157s extensive publication record (100+ studies) provides the broadest preclinical safety dataset for either compound
This analysis pooled results from trials of participants with mild cognitive impairment (6 trials) and trials of participants without cognitive impairment (15 trials)
US$ 22.88
US$ 26.80
US$ 25.00
